Replies to post #675725 on NorthWest Biotherapeutics Inc (NWBO)

[The Danish Dude]

There's nothing "have worked with in the past".

There's RIGHT NOW!

As I have now undisputably shown, the grant from NWBO, is directly traceble to the ATL-DC and poly-iclc trial and the upcoming Nature article.

The puzzle is carved out for you right here, but please do plead ignorance.

$NWBO

Autologous tumor lysate–pulsed DC vaccination (DCVax-L) in conjunction with TLR agonists (poly-iclc) was already evaluated for safety in newly diagnosed and recurrent glioblastoma patients in 2010https://t.co/UOMlvQNHPr

Let's follow this rabbit down the hole 💪🏻

— 🇩🇰 The Danish Dude 🇩🇰 (@FlemmingBruce) March 2, 2024

This is just ONE of a dozen of pieces of evidence corroborating that fact, but I keep adding to the pile, because paid shills like you DESPERATELY NEED to sow fud about these two combo trials and that DCVax-L is the CENTERPIECE of them.

Oh and by the way.

Robert Prins newest video regarding the SPORE 1 combo trial with DCVax-L and Keytruda.

Robert Prins





You are also gonna love the image of most of the team behind the DCVax-L and poly-iclc trial and coming Nature article.



And this image Robert Prins has reused ...



... from Linda Liaus presentations earlier on about the SPORE 1 project here

insert-text-here

Oh and btw.

JUST ONE piece of information. From UCLA Health. A fabulous article which you will hate.

Upper Left Corner: The SPORE 1 Project

The combo trial with DCVax-L + Keytruda (anti-PD-1) and CSF1R inhibition

DCVax-L .... BAAAAM


And zooming in .... for your viewing pleasure